These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 19435786)

  • 1. Molecular identification of "latent precancers" for endometrial serous carcinoma in benign-appearing endometrium.
    Zhang X; Liang SX; Jia L; Chen N; Fadare O; Schwartz PE; Kong B; Zheng W
    Am J Pathol; 2009 Jun; 174(6):2000-6. PubMed ID: 19435786
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence for a latent precursor (p53 signature) that may precede serous endometrial intraepithelial carcinoma.
    Jarboe EA; Pizer ES; Miron A; Monte N; Mutter GL; Crum CP
    Mod Pathol; 2009 Mar; 22(3):345-50. PubMed ID: 19151662
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endometrial glandular dysplasia with frequent p53 gene mutation: a genetic evidence supporting its precancer nature for endometrial serous carcinoma.
    Jia L; Liu Y; Yi X; Miron A; Crum CP; Kong B; Zheng W
    Clin Cancer Res; 2008 Apr; 14(8):2263-9. PubMed ID: 18369088
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nrf2 expression in endometrial serous carcinomas and its precancers.
    Chen N; Yi X; Abushahin N; Pang S; Zhang D; Kong B; Zheng W
    Int J Clin Exp Pathol; 2010 Dec; 4(1):85-96. PubMed ID: 21228930
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coexisting intraepithelial serous carcinomas of the endometrium and fallopian tube: frequency and potential significance.
    Jarboe EA; Miron A; Carlson JW; Hirsch MS; Kindelberger D; Mutter GL; Crum CP; Nucci MR
    Int J Gynecol Pathol; 2009 Jul; 28(4):308-15. PubMed ID: 19483636
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Significance of p53 expression in background endometrium in endometrial carcinoma.
    Nguyen TT; Hachisuga T; Urabe R; Kurita T; Kagami S; Kawagoe T; Shimajiri S; Nabeshima K
    Virchows Arch; 2015 Jun; 466(6):695-702. PubMed ID: 25788166
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The oncofetal protein IMP3: a novel biomarker for endometrial serous carcinoma.
    Zheng W; Yi X; Fadare O; Liang SX; Martel M; Schwartz PE; Jiang Z
    Am J Surg Pathol; 2008 Feb; 32(2):304-15. PubMed ID: 18223334
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential expression of WT1 and p53 in serous and endometrioid carcinomas of the endometrium.
    Egan JA; Ionescu MC; Eapen E; Jones JG; Marshall DS
    Int J Gynecol Pathol; 2004 Apr; 23(2):119-22. PubMed ID: 15084839
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serous endometrial intraepithelial carcinoma arising in adenomyosis: a report of 5 cases.
    Abushahin N; Zhang T; Chiang S; Zhang X; Hatch K; Zheng W
    Int J Gynecol Pathol; 2011 May; 30(3):271-81. PubMed ID: 21464726
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of a novel oncofetal mRNA-binding protein IMP3 in endometrial carcinomas: diagnostic significance and clinicopathologic correlations.
    Li C; Zota V; Woda BA; Rock KL; Fraire AE; Jiang Z; Lu D; Xu B; Dresser K; Lutman CV; Fischer AH
    Mod Pathol; 2007 Dec; 20(12):1263-8. PubMed ID: 17885673
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endometrial glandular dysplasia: a newly defined precursor lesion of uterine papillary serous carcinoma. Part I: morphologic features.
    Zheng W; Liang SX; Yu H; Rutherford T; Chambers SK; Schwartz PE
    Int J Surg Pathol; 2004 Jul; 12(3):207-23. PubMed ID: 15306933
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Concurrent endometrial intraepithelial carcinoma (EIC) and serous ovarian cancer: can EIC be seen as the precursor lesion?
    Roelofsen T; van Kempen LC; van der Laak JA; van Ham MA; Bulten J; Massuger LF
    Int J Gynecol Cancer; 2012 Mar; 22(3):457-64. PubMed ID: 22249577
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serous papillary carcinoma of the endometrium arising from endometrial polyps: a clinical, histological, and immunohistochemical study of 13 cases.
    Trahan S; Têtu B; Raymond PE
    Hum Pathol; 2005 Dec; 36(12):1316-21. PubMed ID: 16311126
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Primary sources of pelvic serous cancer in patients with endometrial intraepithelial carcinoma.
    Jia L; Yuan Z; Wang Y; Cragun JM; Kong B; Zheng W
    Mod Pathol; 2015 Jan; 28(1):118-27. PubMed ID: 24925054
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Equivalent Survival of p53 Mutated Endometrial Endometrioid Carcinoma Grade 3 and Endometrial Serous Carcinoma.
    Brett MA; Atenafu EG; Singh N; Ghatage P; Clarke BA; Nelson GS; Bernardini MQ; Köbel M
    Int J Gynecol Pathol; 2021 Mar; 40(2):116-123. PubMed ID: 32265358
    [TBL] [Abstract][Full Text] [Related]  

  • 16. p53 signature and serous tubal in-situ carcinoma in cases of primary tubal and peritoneal carcinomas and serous borderline tumors of the ovary.
    Leonhardt K; Einenkel J; Sohr S; Engeland K; Horn LC
    Int J Gynecol Pathol; 2011 Sep; 30(5):417-24. PubMed ID: 21804388
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Precursors of endometrial clear cell carcinoma.
    Fadare O; Liang SX; Ulukus EC; Chambers SK; Zheng W
    Am J Surg Pathol; 2006 Dec; 30(12):1519-30. PubMed ID: 17122507
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A candidate precursor to serous carcinoma that originates in the distal fallopian tube.
    Lee Y; Miron A; Drapkin R; Nucci MR; Medeiros F; Saleemuddin A; Garber J; Birch C; Mou H; Gordon RW; Cramer DW; McKeon FD; Crum CP
    J Pathol; 2007 Jan; 211(1):26-35. PubMed ID: 17117391
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mixed endometrial carcinomas with a "low-grade serous"-like component: a clinicopathologic, immunohistochemical, and molecular genetic study.
    Espinosa I; D'Angelo E; Corominas M; Gonzalez A; Prat J
    Hum Pathol; 2018 Jan; 71():65-73. PubMed ID: 29079180
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stromal p16 expression is significantly increased in endometrial carcinoma.
    Yoon G; Koh CW; Yoon N; Kim JY; Kim HS
    Oncotarget; 2017 Jan; 8(3):4826-4836. PubMed ID: 27902476
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.